I am an active day trader spending the majority of my time analyzing earnings reports and watching commodities and derivatives. I have a Masters Degree in Economics from Westminster University with previous roles counting Investment Banking.
Address: 3966 Euclid Avenue, San Luis Obispo, CA 93401, USA
Phone: (+1) 805-361-3810
Latest posts by Loretta Morfin (see all)
NEW YORK, June 30, 2019 – Shares of Moog Inc. (NYSE: MOG-A) inclined 3.71% to $93.61. The stock traded total volume of 1.121M shares lower than the average volume of 119.55K shares.
Moog Inc. (MOG.A) reported fiscal second-quarter earnings of $42.40M.
Total Aircraft Controls segment sales in the quarter were $321.0M, up 3% year over year. Military aircraft sales of $155.0M were unchanged. F-35 Joint Strike Fighter sales increased 4%. Other OEM military sales were down 11%, to $68.0M, attributed to lower sales in helicopter product lines. Military aftermarket sales were $53.0M, up 13% on F-35 and V-22 program activity.
Commercial aircraft revenues increased 6%, to $166.0M. Boeing OEM sales were $64.0M, up 12% on strong 787 sales. Airbus sales of $44.0M increased 12% on A350 deliveries. Other legacy OEM sales were higher year over year. Commercial aftermarket sales were down 9%, mostly because of lower business jet and 787 activities.
Space and Defense segment sales were $165.0M, up 15% year over year. Defense sales were up 30%, to $111.0M, on increases in all product lines. Space sales were off 8%, attributed to decreases in sales of space avionics and satellite products, contrast to last year’s strong second quarter.
Industrial Systems segment sales in the quarter were $233.0M, mostly unchanged from last year’s second quarter. The Company’s exit from the wind pitch controls business last year reduced energy market sales, but was offset, in part, by higher sales for energy exploration applications. Industrial automation sales were up a healthy 7%, to $116.0M, assisted by the large motor acquisition in the Czech Republic. Medical market sales were 6% higher on strong enteral pump sales. Simulation and test sales were mostly unchanged.
Total backlog was $2.20B, with consolidated 12-month backlog at $1.60B, up 26% from a year ago.
MOG-A has the market capitalization of $3.32B and its EPS growth ratio for the past five years was 4.20%. The return on assets ratio of the Company was 5.60% while its return on investment ratio stands at 5.60%. Price to sales ratio was 1.19 while 95.80% of the stock was owned by institutional investors.